A Research Study for Patients With Metastatic Renal Cell Carcinoma
NCT00106613
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Renal Cell
Neoplasm Metastasis
Interventions
DRUG:
FK228 (romidepsin)
Sponsor
Celgene